Amarin (AMRN) Announces sNDA Submission for BASF as additional Vascepa Supplier
Tweet Send to a FriendGet Alerts AMRN Hot Sheet
Down)
Trade AMRN Now!
Amarin Corporation plc (Nasdaq: AMRN) announced today the late December 2012 submission of a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for BASF as an additional Vascepa® (icosapent ethyl) active pharmaceutical ingredient (API) supplier.
"This sNDA submission for BASF follows the recent sNDA submission for Chemport and marks our third Vascepa API supplier sNDA submission, with a submission for the addition of a fourth planned supplier expected in the first half of 2013," stated Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. "The BASF submission represents an additional step toward the goal of expanding our global supply chain to support expected Vascepa demand, diversify our supply base and ensure cost-efficient supply."
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"This sNDA submission for BASF follows the recent sNDA submission for Chemport and marks our third Vascepa API supplier sNDA submission, with a submission for the addition of a fourth planned supplier expected in the first half of 2013," stated Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. "The BASF submission represents an additional step toward the goal of expanding our global supply chain to support expected Vascepa demand, diversify our supply base and ensure cost-efficient supply."
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- St. Jude Medical (STJ) Issues Encouraging Update for EnligHTN™ Multi-Electrode Renal Denervation System Following One Year
- FMC Tech (FTI) Receives Order from Shell (RDS-A) for Stones Field
- Marathon Oil (MRO) Terminates Athabasca Oil Sale
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
